The global population of multimorbid older people is growing steadily. Multimorbidity is the
principal cause of complex polypharmacy, which in turn is the prime risk factor for …

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide. Age and smoking are common risk factors for COPD and other illnesses, often …

Importance Off-label use of prescription drugs has been identified as an important
contributor to preventable adverse drug events (ADEs) in children. Despite concerns …

The pattern of patients admitted to internal medicine wards has dramatically changed in the
last 20–30 years. Elderly people are now the most rapidly growing proportion of the patient …

Aging is known to be associated with an increased prevalence of multiple chronic diseases,
which frequently causes the use of complex therapeutic regimens. The aging process is …

Background The aim of the present study was to develop and validate a method of
identifying elderly patients who are at increased risk for an adverse drug reaction (ADR) …

Trial design: to further validate the FORTA (Fit fOR The Aged) concept, a bicentric
randomised, controlled trial was run in two geriatric clinics. Methods: patients (≥ 65 years,≥ …

Introduction The proportion of the elderly is constantly increasing and by the year 2025 20%
of the population will be above 65 years of age. With advanced age, subjects will develop …

Polypharmacy is a problem of growing interest in geriatrics with the increase in drug
consumption in recent years, particularly among people aged> 65 years. The main reasons …

Objectives To identify factors that predict repeat admission to hospital for adverse drug
reactions (ADRs) in older adults. Design Population based retrospective cohort study …